Arg-Gly-Asp-D-Phe-Lys peptide-modified PEGylated dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of breast carcinoma. (July 2015)
- Record Type:
- Journal Article
- Title:
- Arg-Gly-Asp-D-Phe-Lys peptide-modified PEGylated dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of breast carcinoma. (July 2015)
- Main Title:
- Arg-Gly-Asp-D-Phe-Lys peptide-modified PEGylated dendrimer-entrapped gold nanoparticles for targeted computed tomography imaging of breast carcinoma
- Authors:
- Li, Kangan
Zhang, Zhuoli
Zheng, Linfeng
Liu, Hong
Wei, Wei
Li, Zhiyu
He, Zhiyan
Larson, Andrew C
Zhang, Guixiang - Abstract:
- Aim: To investigate cyclo (Arg-Gly-Asp-D-Phe-Lys) peptide (RGD)-modified PEGylated dendrimer-entrapped gold nanoparticles (PEGylated Au DENPs-RGD) for targeted computed tomography (CT) imaging of breast carcinomas.Materials & methods: PEGylated Au DENPs-RGD were synthesized and characterized. Then, the PEGylated Au DENPs-RGD for targeted CT imaging were investigated using the MDA-MB-435 cell line, an integrin-rich breast carcinoma cells, and mice with MDA-MB-435 xenograft tumors. Finally, silver enhancement staining and integrin αv β3 immunohistochemistry of the tumors were performed.Results: The synthesized PEGylated Au DENPs-RGD were spherical, water dispersible and biocompatible nanoprobes with a gold nanoparticle core size of 2.8 nm. Due to the presence of the Au nanoparticles, the PEGylated Au DENPs-RGD displayed a higher x-ray attenuation intensity than Omnipaque at the same Au or I concentrations. The conjugated RGD ligand can specifically identify and target overexpressed integrin receptors on MDA-MB-435 cells. After intravenous injection, these nanoprobes accumulated in the targeted area of mice with MDA-MB-435 xenograft tumors, which enabled the tumor to be detected by CT imaging. The histological results confirmed the imaging results.Conclusion: The PEGylated Au DENPs-RGD can be used as targeted nanoprobes with good biocompatibility for targeted CT imaging and diagnosis of integrin-positive tumors.
- Is Part Of:
- Nanomedicine. Volume 10:Number 14(2015)
- Journal:
- Nanomedicine
- Issue:
- Volume 10:Number 14(2015)
- Issue Display:
- Volume 10, Issue 14 (2015)
- Year:
- 2015
- Volume:
- 10
- Issue:
- 14
- Issue Sort Value:
- 2015-0010-0014-0000
- Page Start:
- 2185
- Page End:
- 2197
- Publication Date:
- 2015-07
- Subjects:
- breast carcinoma -- dendrimers -- gold nanoparticles -- integrin -- RGD peptides -- targeted computed tomography imaging
Nanotechnology -- Periodicals
Medical technology -- Periodicals
Nanotechnology -- Therapeutic use -- Periodicals
610.28 - Journal URLs:
- http://www.futuremedicine.com/loi/nnm ↗
http://www.futuremedicine.com/ ↗ - DOI:
- 10.2217/nnm.15.59 ↗
- Languages:
- English
- ISSNs:
- 1743-5889
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.015000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 20185.xml